Holen Sie sich die Stockscreener-App
33.28
1.28%
-0.43
Handel nachbörslich:
33.28
Vtv Therapeutics Inc Aktie (VTVT) Neueste Nachrichten
HC Wainwright Forecasts Higher Earnings for vTv Therapeutics - MarketBeat
Evercore ISI initiates vTv Therapeutics stock with outperform rating By Investing.com - Investing.com Canada
This Jabil Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Evercore ISI Initiates vTv Therapeutics at Outperform With $44 Price Target - marketscreener.com
Evercore ISI Initiates Coverage on VTVT with Outperform Rating | VTVT Stock News - GuruFocus
Research Analysts Set Expectations for VTVT Q1 Earnings - MarketBeat
vTv Therapeutics (NASDAQ:VTVT) Share Price Crosses Below 50-Day Moving AverageShould You Sell? - MarketBeat
vTv Therapeutics (VTVT) Projected to Post Earnings on Thursday - Defense World
Avoiding Lag: Real-Time Signals in (VTVT) Movement - Stock Traders Daily
BTIG Maintains Buy on vTv Therapeutics Inc (VTVT) March 11, 2026 - Meyka
BTIG reiterates Buy on vTv Therapeutics stock, $49 target maintained By Investing.com - Investing.com Canada
VTVT: BTIG Reiterates Buy Rating with Unchanged Price Target | V - GuruFocus
BTIG reiterates Buy on vTv Therapeutics stock, $49 target maintained - Investing.com
vTv Therapeutics 2025 – Pipeline, Clinical Trials, and Patent Portfolio Overview - Minichart
vTv Therapeutics price target raised to $55 from $35 at Alliance Global - TipRanks
VTv Therapeutics: Q4 Earnings Snapshot - theheraldreview.com
vTv Therapeutics Highlights Cadisegliatin Phase 3 and Cash Runway - TipRanks
vTv Therapeutics 2025 10-K: $0.0M Revenue, $(26.97)M Net Loss - TradingView
VTv Therapeutics: Fourth Quarter Earnings Overview - Bitget
VTV Therapeutics (VTVT) Quarterly & Annual Financial Results 2026News and StatisticsIndexBox - IndexBox - Market Intelligence Platform
VTVT Stock Bolstered by Strong Financials and Strategic Advances - GuruFocus
vTv Therapeutics reports Q4 EPS (58c), consensus ($1.09) - TipRanks
vTv Therapeutics (VTVT) boosts cash, advances Phase 3 CATT1 trial - Stock Titan
vTv Therapeutics Q4 net loss widens on higher expenses - TradingView
vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - Weekly Voice
Vtv Therapeutics: Capital Efficiency and Clinical Catalysts Under Scrutiny - AD HOC NEWS
Aug Shorts: Will vTv Therapeutics Inc outperform the market in YEAREarnings Risk Report & Verified Technical Trade Signals - baoquankhu1.vn
How vTv Therapeutics Inc. (5VT0) stock correlates with oil marketsJuly 2025 WrapUp & Fast Entry High Yield Tips - Naître et grandir
vTv Therapeutics (VTVT) Secures Global Partnership for PDE4 Inhibitor HPP737 - Yahoo Finance
12 Most Promising Micro-Cap Stocks According to Analysts - Insider Monkey
Discipline and Rules-Based Execution in VTVT Response - Stock Traders Daily
VTv Therapeutics: Cadisegliatin's Phase 3 CATT1 Readout Is The Next Catalyst - Seeking Alpha
VTVT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
vTv Therapeutics Inc. (NASDAQ:VTVT) Short Interest Up 61.2% in February - Defense World
VTVT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
VTVT PE Ratio & Valuation, Is VTVT Overvalued - Intellectia AI
vTv Therapeutics Highlights Cadisegliatin Progress and Financial Strength - TipRanks
vTv Therapeutics posts updated investor presentation highlighting Phase 3 cadisegliatin readout and $118.5M liquidity - TradingView
vTv Therapeutics (VTVT) spotlights cadisegliatin Phase 3 and cash runway - Stock Titan
VTVT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Quarterly Earnings: Can US Physical Therapy Inc deliver consistent EPS growth2025 Earnings Impact & Breakout Confirmation Trade Signals - baoquankhu1.vn
What are analysts’ price targets for vTv Therapeutics Inc.2025 Retail Activity & Short-Term Trading Opportunity Alerts - mfd.ru
Can vTv Therapeutics Inc. sustain earnings growthProfit Target & Long-Term Safe Investment Plans - mfd.ru
vTv Therapeutics (NASDAQ:VTVT) Shares Pass Above Fifty Day Moving AverageWhat's Next? - MarketBeat
Stock Analysis: What are analysts price targets for vTv Therapeutics IncMarket Activity Report & Weekly Watchlist of Top Performers - baoquankhu1.vn
vTv Therapeutics (VTVT) CFO granted 44,969 stock options at $36.92 - Stock Titan
Behavioral Patterns of VTVT and Institutional Flows - Stock Traders Daily
What’s next for vTv Therapeutics Inc. stockMarket Trend Report & AI Powered Buy/Sell Recommendations - mfd.ru
Why vTv Therapeutics Inc. stock could see breakout soonJuly 2025 Fed Impact & High Accuracy Swing Trade Signals - mfd.ru
vTv Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Type 1 diabetes drug developer vTv set for two investor conferences - Stock Titan
Will vTv Therapeutics Inc. stock recover after earningsShort Setup & Stock Portfolio Risk Management - mfd.ru
Is vTv Therapeutics Inc.’s ROE strong enoughQuarterly Growth Report & Smart Allocation Stock Reports - mfd.ru
Aug Retail: Does vTv Therapeutics Inc have strong fundamentalsEarnings Overview Report & Stepwise Swing Trade Plans - baoquankhu1.vn
(VTVT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Q1 EPS Forecast for vTv Therapeutics Increased by Analyst - Defense World
HC Wainwright Boosts Earnings Estimates for vTv Therapeutics - MarketBeat
Will vTv Therapeutics Inc outperform the market in YEARQuarterly Trade Report & Stepwise Trade Signal Guides - baoquankhu1.vn
Analysts Are Bullish on These Healthcare Stocks: vTv Therapeutics (VTVT), Acumen Pharmaceuticals (ABOS) - The Globe and Mail
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):